Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Tuberculosis

  Free Subscription


26.08.2019

2 Antimicrob Agents Chemother
1 Chest
1 Clin Infect Dis
1 Emerg Infect Dis
1 Infect Immun
14 Int J Tuberc Lung Dis
1 J Infect Dis
2 Lancet
4 Lancet Respir Med
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. TANNER L, Evans JC, Seldon R, Jordaan A, et al
    In vitro efficacies, ADME, and pharmacokinetic properties of phenoxazine derivatives active against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Aug 19. pii: AAC.01010.
    PubMed     Text format     Abstract available

  2. XIAO S, Guo H, Weiner WS, Maddox C, et al
    Revisiting the beta-lactams for tuberculosis therapy: a compound-compound synthetic lethality approach.
    Antimicrob Agents Chemother. 2019 Aug 19. pii: AAC.01319.
    PubMed     Text format     Abstract available


    Chest

  3. WANG G, Wang S, Yang X, Sun Q, et al
    Accuracy of Xpert MTB/RIF Ultra for the diagnosis of pleural tuberculosis in a multicentre cohort study.
    Chest. 2019 Aug 19. pii: S0012-3692(19)31460-6. doi: 10.1016/j.chest.2019.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  4. ZELNER J
    Is a more data-driven approach the future of Tuberculosis transmission modeling?
    Clin Infect Dis. 2019 Aug 17. pii: 5550891. doi: 10.1093.
    PubMed     Text format    


    Emerg Infect Dis

  5. KUMAR A, Kunoor A, Eapen M, Singh PK, et al
    Blastomycosis Misdiagnosed as Tuberculosis, India.
    Emerg Infect Dis. 2019;25:1776-1777.
    PubMed     Text format     Abstract available


    Infect Immun

  6. HOFT SG, Sallin MA, Kauffman KD, Sakai S, et al
    Erratum for Hoft et al., "The Rate of CD4 T Cell Entry into the Lungs during Mycobacterium tuberculosis Infection Is Determined by Partial and Opposing Effects of Multiple Chemokine Receptors".
    Infect Immun. 2019;87.
    PubMed     Text format    


    Int J Tuberc Lung Dis

  7. SGRO A, Ots R, Brunetti E
    Impact of World Tuberculosis Day on digital awareness of tuberculosis: analyses using Google Trends.
    Int J Tuberc Lung Dis. 2019;23:824-829.
    PubMed     Text format     Abstract available

  8. PHILIPSEN RHHM, Sanchez CI, Melendez J, Lew WJ, et al
    Automated chest X-ray reading for tuberculosis in the Philippines to improve case detection: a cohort study.
    Int J Tuberc Lung Dis. 2019;23:805-810.
    PubMed     Text format     Abstract available

  9. ARMSTRONG LR, Winston CA, Stewart B, Tsang CA, et al
    Changes in tuberculosis epidemiology, United States, 1993-2017.
    Int J Tuberc Lung Dis. 2019;23:797-804.
    PubMed     Text format     Abstract available

  10. HUANGFU P, Ugarte-Gil C, Golub J, Pearson F, et al
    The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:783-796.
    PubMed     Text format     Abstract available

  11. BOGDANOVA E, Mariandyshev O, Hinderaker SG, Nikishova E, et al
    Mass screening for active case finding of pulmonary tuberculosis in the Russian Federation: how to save costs.
    Int J Tuberc Lung Dis. 2019;23:830-837.
    PubMed     Text format     Abstract available

  12. TALBOT EA, Pai M
    Tackling drug-resistant tuberculosis: we need a critical synergy of product and process innovations.
    Int J Tuberc Lung Dis. 2019;23:774-782.
    PubMed     Text format     Abstract available

  13. DEDICOAT M
    Tuberculosis control in the United States: strengths, weaknesses, opportunities, threats.
    Int J Tuberc Lung Dis. 2019;23:773.
    PubMed     Text format    

  14. IRFAN S, Rao N, Irfan M, Iftikhar I, et al
    Utility of the microcolony method for evaluation of multidrug-resistant tuberculosis patients in Karachi, Pakistan.
    Int J Tuberc Lung Dis. 2019;23:838-843.
    PubMed     Text format     Abstract available

  15. YUEN CM, Agaya J, Mchembere W, Okelloh D, et al
    Optimizing the efficiency of tuberculosis active case-finding in health facilities and communities.
    Int J Tuberc Lung Dis. 2019;23:844-849.
    PubMed     Text format     Abstract available

  16. LEE M, Han J, Kim YR, Kwak N, et al
    Multidrug-resistant tuberculosis in South Korea: a retrospective analysis of national registry data in 2011-2015.
    Int J Tuberc Lung Dis. 2019;23:850-857.
    PubMed     Text format     Abstract available

  17. RUSWA N, Mavhunga F, Roscoe JC, Beukes A, et al
    Second nationwide anti-tuberculosis drug resistance survey in Namibia.
    Int J Tuberc Lung Dis. 2019;23:858-864.
    PubMed     Text format     Abstract available

  18. COX SN, Elf JL, Lokhande R, Ogale YP, et al
    Mobile phone access and comfort: implications for HIV and tuberculosis care in India and South Africa.
    Int J Tuberc Lung Dis. 2019;23:865-872.
    PubMed     Text format     Abstract available

  19. MORASERT T
    In reply to Comments on "Prevalence and risk factors associated with tuberculosis disease in Suratthani Central Prison, Thailand".
    Int J Tuberc Lung Dis. 2019;23:874-875.
    PubMed     Text format    

  20. LIN Y, Harries AD, Kumar AMV, Critchley JA, et al
    Tackling diabetes mellitus and tuberculosis: a new Union guide on the management of diabetes-tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:771-772.
    PubMed     Text format    


    J Infect Dis

  21. RIOU C, Jhilmeet N, Rangaka MX, Wilkinson RJ, et al
    Tuberculosis antigen-specific T cell responses during the first 6 months of antiretroviral treatment.
    J Infect Dis. 2019 Aug 17. pii: 5550849. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet

  22. REID MJA, Goosby E
    A tuberculosis-free world: is it a delusion? - Authors' reply.
    Lancet. 2019 Aug 12. pii: S0140-6736(19)31411.
    PubMed     Text format    

  23. ATRE S
    A tuberculosis-free world: is it a delusion?
    Lancet. 2019 Aug 12. pii: S0140-6736(19)31623.
    PubMed     Text format    


    Lancet Respir Med

  24. ESMAIL H, Lipman MC, Nunn A, Walker TM, et al
    Individualising therapy for drug-sensitive tuberculosis.
    Lancet Respir Med. 2019 Aug 16. pii: S2213-2600(19)30247.
    PubMed     Text format    

  25. MCSHANE H
    Insights and challenges in tuberculosis vaccine development.
    Lancet Respir Med. 2019 Aug 12. pii: S2213-2600(19)30274.
    PubMed     Text format     Abstract available

  26. TAMERIS M, Mearns H, Penn-Nicholson A, Gregg Y, et al
    Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.
    Lancet Respir Med. 2019 Aug 12. pii: S2213-2600(19)30251.
    PubMed     Text format     Abstract available

  27. ACHKAR JM
    Prospects and challenges of a new live tuberculosis vaccine.
    Lancet Respir Med. 2019 Aug 12. pii: S2213-2600(19)30277.
    PubMed     Text format    


    PLoS One

  28. SHEN Y, Yu G, Zhong F, Kong X, et al
    Diagnostic accuracy of the Xpert MTB/RIF assay for bone and joint tuberculosis: A meta-analysis.
    PLoS One. 2019;14:e0221427.
    PubMed     Text format     Abstract available

  29. PUGA MAM, Bandeira LM, Pompilio MA, Rezende GR, et al
    Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required.
    PLoS One. 2019;14:e0221265.
    PubMed     Text format     Abstract available

  30. SIDDIQUI S, Brooks MB, Malik AA, Fuad J, et al
    Evaluation of GenoType MTBDRplus for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan.
    PLoS One. 2019;14:e0221485.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: